Partnership Growth Neuroelectrics has recently partnered with Neuronostics to deliver integrated EEG solutions for pharmaceutical, CROs, and academic partners, signaling openness to strategic collaborations that expand go-to-market channels and data analytics capabilities.

Clinical Telemedicine Recent telemedicine pilot results for depression using Starstim tDCS indicate a proven remote therapy pathway, presenting an opportunity to license or co-sell telehealth-enabled brain stimulation solutions to clinics, payers, and mental health platforms.

3D Brain Modeling Development of detailed 3D brain models and Neurotwins suggests potential for advanced personalized therapies and biomarker-driven trials, enabling partnerships with pharma, CROs, and research institutions seeking precision neuromodulation solutions.

Global Commercial Presence With headquarters in Barcelona and a noted U.S. presence, Neuroelectrics offers a bilateral market approach for cross-border sales, software licenses, and service contracts, appealing to international medical device distributors and research labs.

Financial Health & Growth Series A funding in 2021 and a revenue range of 1-10 million position the company as a growth-focused partner, suitable for collaboration on funded research programs, joint ventures, or co-development initiatives that leverage its hardware-software stack.